Genomics

Dataset Information

ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway


ABSTRACT: ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway

PROVIDER: PRJNA548537 | ENA |

REPOSITORIES: ENA